Trial Profile
Comparison of oral and patch forms of hormonal contraception on plasma lipoproteins, glycemia, clotting factors, indices of inflammation and vascular reactivity
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Estradiol/norgestimate (Primary) ; Ethinylestradiol/norelgestromin (Primary)
- Indications Pregnancy
- Focus Pharmacodynamics
- 11 Feb 2011 Planned End Date changed from 1 Jan 2009 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 20 Aug 2008 Planned end date changed from 1 Dec 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.
- 20 Aug 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.